David Roche, strategist at Quantum Strategy, discusses the Bank of Japan's latest interest rate decision and its outlook in ...

David Roche of Quantum Strategy discusses the limited impact to the Euro and French OAT spreads following the recent ...

Crosby Kemper full conversation with Director and CEO of the Heard Museum, David Roche, to discuss the museum’s role as a central asset in telling and preserving American Indian history and culture.

Roche has struck a $1.5 billion deal to buy Poseida Therapeutics. The takeover will establish off-the-shelf cell therapies, which Roche has said can democratize CAR-Ts, as a new core capability at ...

In the evening hours of Wednesday, June 10, 2015, David Lewis Roche, 76, of West Wyomissing, PA, died in ManorCare, Sinking Spring. Son of the late Irene (Bachschmidt) and John A. Roche ...

Roche’s SKYSCRAPER-01 has fallen down. The phase 3 trial found adding the TIGIT candidate tiragolumab to Roche's approved checkpoint inhibitor had no effect on overall survival (OS) in non-small ...

Roche has signed an agreement to acquire Poseida Therapeutics in a $1.5bn deal. The transaction includes Poseida's clinical and pre-clinical CAR-T therapies and manufacturing capabilities.

Roche, the world's number-one oncology group, will offer Poseida shareholders $9.0 per share and add a further $4.0 per share by way of a non-tradeable certificate to acquire the San Diego ...